Board Of Trustees Of The Leland Stanford Junior University Aravive, Inc. Transaction History

Board Of Trustees Of The Leland Stanford Junior University

  • $1.46 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020
SELL
$6.21 - $14.02 $912,658 - $2.06 Million
-146,966 Closed
0 $0
Q4 2018

Feb 12, 2019
BUY
$3.23 - $8.7 $474,700 - $1.28 Million
146,966 New
146,966 $516,000

Others Institutions Holding ARAV

# of Institutions
2
Shares Held
28.1K
Call Options Held
0
Put Options Held
0
View Full List

About Aravive, Inc.

ARAV Quotes by TradingView
  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track Board Of Trustees Of The Leland Stanford Junior University Portfolio

Follow Board Of Trustees Of The Leland Stanford Junior University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Board Of Trustees Of The Leland Stanford Junior University, based on Form 13F filings with the SEC.

News

Stay updated on Board Of Trustees Of The Leland Stanford Junior University with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email